Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2‐Year Observational Study

AIMS: We evaluate safety and efficacy of autologous bone marrow‐derived mesenchymal stem cells (MSCs) as a potential treatment for neuromyelitis optica spectrum disorder (NMOSD). METHODS: Fifteen patients with NMOSD were recruited. All patients received a single intravenous infusion of 1.0 × 10(8) a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Autores principales: Fu, Ying, Yan, Yaping, Qi, Yuan, Yang, Li, Li, Ting, Zhang, Ningnannan, Yu, Chunshui, Su, Lei, Zhang, Rui, Shen, Yi, Lin, Song, Liu, Qiang, Shao, Zonghong, Han, Zhongchao, Shi, Fu‐Dong
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492909/
https://ncbi.nlm.nih.gov/pubmed/27219819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12559
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares